Navigation Links
Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
Date:7/30/2009

o received ANA773 at 1600 mg. Anadys expects to present further results from this study later this year and intends to explore partnership opportunities as a potential path to continue the development of ANA773.
  • Reported PK/PD Data for ANA773 in HCV at EASL. In April 2009, the pharmacokinetic (PK) and pharmacodynamic (PD) data from the healthy volunteer portion of the Phase I clinical trial of ANA773 in HCV were reported at the EASL conference. ANA773 was generally well tolerated with no serious adverse events. Plasma drug levels were proportional to dose, and there was a dose-dependent induction of well-recognized interferon dependent biomarkers.
  • Phase I Clinical Trial in Oncology. In order to focus its resources on ANA598, Anadys recently elected to stop enrollment of new patients in the ongoing Phase I oncology trial of ANA773. Anadys plans for currently enrolled patients to continue to receive ANA773 until disease progression is observed and to conclude the trial once all patients reach this point.
  • Webcast of Conference Call

    Anadys will host a conference call at 5:00 pm Eastern Daylight Time today to discuss its second quarter 2009 financial results and highlights and to provide an update on its development programs. A live webcast of the call will be available online at www.anadyspharma.com. A telephone replay will also be available approximately one hour after completion of the call. To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 85411914. The webcast and telephone replay will be available through August 13, 2009.

    About Anadys

    Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of
    '/>"/>

    SOURCE Anadys Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related biology technology :

    1. Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
    2. Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
    3. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
    4. Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
    5. Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry
    6. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
    7. Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
    8. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
    9. Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients
    10. Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
    11. Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/24/2015)... (PRWEB) April 24, 2015 Seoul ... technology for various applications in the lighting market. ... successful installations of this technology in emerging markets ... for a wide range of applications such as ... and decorative lighting. , First launched in 2005 ...
    (Date:4/23/2015)... 2015 The Thomas Brain Health ... a groundbreaking pilot study to see if early ... as little as three to six months. , ... nutritional medicine—will aggressively target and simultaneously treat the ... aging brain. These include oxidative stress, neuroinflammation, mitochondrial ...
    (Date:4/23/2015)... April 23, 2015 Six startups ... on April 4-17 as part of the U.S.-Russia ... fourth group of biotechnology startups to participate in ... Novgorod (UNN) and the University of Maryland (UMD) ... between their respective universities in the biomedical industry ...
    (Date:4/23/2015)... (PRWEB) April 23, 2015 ... refer to a series of genetic tests that ... fibrosis, Lou Gehrig's disease, Huntington's disease, and Alzheimer's ... the gene composition and interaction in diseased tissue/cells ... as well as the response to treatment, such ...
    Breaking Biology Technology:Acrich Technology from Seoul Semiconductor Adopted in Installations Worldwide 2New Study Looks to Reverse Alzheimer’s Disease 2New Study Looks to Reverse Alzheimer’s Disease 3U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 2U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 3U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 4Increasing Disease Prevalence & Focus on Preventive Healthcare Drive the Predictive Diagnostics Market, According to a New Report by Global Industry Analysts, Inc. 2Increasing Disease Prevalence & Focus on Preventive Healthcare Drive the Predictive Diagnostics Market, According to a New Report by Global Industry Analysts, Inc. 3
    ... , , MARKHAM, ON, Nov. 25 /PRNewswire/ ... to its Board of Directors. Dr. Moldt will replace Mr. ... Board. The number of Board members remains unchanged at six ... to the board and look forward to benefiting from his ...
    ... 25 Ardea Biosciences, Inc. (Nasdaq: RDEA ) announced ... officer, will present at the Piper Jaffray 21st Annual Health ... Annual Health Care Conference,Date: Tuesday, ... Eastern Time,Location: The New York Palace Hotel, New York, ...
    ... ... ... Ambassador for International Investment, and Chairman and CEO of the Invest in France Agency, , ... initiatives adopted by France to further develop the financial, fiscal and academic landscape for innovation ...
    Cached Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
    (Date:3/30/2015)... DUBLIN , Mar. 26, 2015 Research and ... addition of the "Global Gesture Recognition Market in ... The analysts forecast the Global Gesture Recognition market ... 12.8% over the period 2013-2018. Gesture recognition ... respond to different gestures of an individual. Gesture recognition ...
    (Date:3/24/2015)... 2015   NexID Biometrics LLC, whose spoof-mitigation ... today announced the beginning of shipments of version 2.0 ... The company, based in Potsdam, N.Y. ... Expo, which began here today at the Walter E. ... of its SDK boosts the accuracy rate range to ...
    (Date:3/23/2015)... 23, 2015  In the 2014 fiscal year, irs.gov ... losses. This figure accounts for a fraction of the ... Nilson Report, exceeds $11 billion globally. The polygraph has ... crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test in ...
    Breaking Biology News(10 mins):Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
    ... For his groundbreaking research focusing on population biology and ... Science researcher Dr. David Secor has been awarded the ... Award for Excellence. As a fisheries biologist, a ... species that often have management conflicts: striped bass, bluefin ...
    ... professor of entomology at the University of California, Riverside, has ... Memorial Award for "his enthusiastic and innovative applied research in ... the research of armored and unarmored scale insect control using ... Professor Luck and also points out the value of UC ...
    ... suggests that jewel scarab beetles find each otherand hide ... 3D effects for the blockbuster movie Avatar. According ... scarab species Chrysina gloriosa can distinguish between ... the beetles with a tremendous advantage, the researchers say, ...
    Cached Biology News:UMCES fisheries biologist Dr. David Secor receives USM Regent's Faculty Award for research 2UC Riverside entomologist recognized for research in citrus entomology 2Beetles stand out using 'Avatar' tech 2
    ... Quidel's depleted sera are specifically depleted ... exception of the depleted protein, the alternative ... reagents are therefore ideal for the detection ... ,Depleted sera have been used to assess ...
    ... by luciferase-cDNA transfected cell lines has proven ... development of reporter gene assays in which ... for the transcription of other genes. The ... to advantages such as high sensitivity and ...
    ... is a technique used to reveal two ... Staining Kit is a Zymed polymer double ... simultaneously in the same human cell or ... can be identified using two different primary ...
    ... the D-2000, but comes with a shutter (controlled ... The D-2000 Deuterium Light Source produces a ... deep-UV versions of the light source are available, ... powerful and stable lamp provides peak-to-peak stability of ...
    Biology Products: